Barrett's esophagus: what it is and its cancer risk

This page is for people recently told they have Barrett esophagus, and their families. It explains what has changed in the lining, how often it leads to cancer, and what can be done.

Being told your food pipe has "changed" after an endoscopy lands hard. Many people leave that appointment thinking cancer is now just a matter of time. The numbers in the National Cancer Institute's prevention summary say something different, and they are worth seeing directly.

The lower part of the esophagus is normally lined with flat, layered cells, the kind of surface built for food passing through. In Barrett esophagus, that surface gets replaced by an intestinal-type lining, the kind you would expect further down the gut.

NCI describes the condition as developing after long-standing GERD, the medical name for repeated acid reflux.

Here is the part people come for.

In the data NCI summarizes, patients with Barrett esophagus developed adenocarcinoma of the esophagus at about 1.2 cases per 1,000 person-years. "Person-years" is just a way researchers pool time: 1,000 people followed for one year, or 100 people followed for ten years, comes out the same.

Compared with the general population, that works out to roughly 11 times higher. NCI also notes the absolute risk remains modest.

A big multiple applied to a small starting number still gives you a small number. That is the honest shape of this diagnosis.

The reflux connection is real, and it can be measured. In the evidence NCI cites, daily heartburn together with regurgitation carried an eightfold higher risk, with a confidence range from 4.5 to 14.0. Frequent, long-running symptoms are the pattern that matters, not the occasional heavy meal that repeats on you.

But the link runs oddly in the other direction too. NCI notes that over half of esophageal adenocarcinoma cases are not tied to reflux symptoms at all. Plenty of people who get this cancer never had troublesome heartburn to warn them.

Both facts are true at the same time, and neither one cancels out the other. Symptoms are a useful signal, but not a reliable one.

For Barrett esophagus with dysplasia, meaning cells that look abnormal but are not cancer, NCI describes radiofrequency ablation. This treatment uses heat, delivered through an endoscope, to remove the abnormal lining. In the trial numbers cited, the lining was successfully cleared in 90.5% of the treatment group for low-grade dysplasia, versus 22.7% in the control group.

That is a large gap. Whether ablation fits a particular person depends on what the biopsies showed. That is a conversation for the doctor who read your slides, not something to work out from a web page.

If you have been diagnosed, the useful next steps are unglamorous. Find out from your report whether any dysplasia was seen, and at what grade. Get clear on when your next endoscopy is due. Ask your care team how and when to take the reflux treatment you have been given.

If you have not been diagnosed but have had heartburn most days for years, that is worth raising with a doctor. Not because it means cancer, but because ongoing reflux can be treated, and it is the thing driving this whole chain.

And if you are somewhere in the middle, holding a report you do not fully follow, ask for it to be explained line by line. Barrett esophagus is a condition where knowing your own details changes what these numbers actually mean for you.